US5550040A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method, reagents and kits for the detection of Neisseria gonorrhoeae
Assignee: Roche Molecular Systems Inc
•
Filing: 1994-03-17
•
Granted: 1996-08-27
•
Expires: 2014-03-17
Abstract
Abstract Methods, reagents and kits are provided for simultaneously amplifying and detecting polynucleotide sequences in bacteria causing Neisseria gonorrhoeae and/or Chlamydia trachomatis using primers and probes specific for each bacterial species.
Inventors
- 👤 Ashok P. Purohit
- 👤 Sheryl B. Silver
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 05:09
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6888; C12Q1/689; Y; Y10; Y10S; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
257 words
A method for determining the presence or absence of N. gonorrhoeae and/or C. trachomatis in a fluid sample suspected of containing either or both N. gonorrhoeae and C. trachomatis comprising: (a) treating said sample with an aqueous solution containing at least four oligonucleotide primers, two of said primers being capable of hybridizing selectively with the two complementary strands of N. gonorrhoeae DNA which contain the target sequence, said primers having SEQ ID NO: 1 and SEQ ID NO:2, respectively, and the other two primers being capable of hybridizing selectively with the two complementary strands of C. trachomatis DNA which contain the target sequence, said primers having SEQ ID NO:4 and SEQ ID NO:5, respectively, said aqueous solution also containing an inert organic polar solvent as a cosolvent; (b) synthesizing an extension product of each of said primers, which extension product(s) containing the target DNA sequence(s), and amplifying said target sequences(s) if present; (c) treating said sample, after the intended amplification(s), with two oligonucleotide probes: one probe having sequence SEQ ID NO:3 which is uniquely complementary to a sequence in the amplified region of N. gonorrhoeae, and a second probe having sequence SEQ ID NO:6 which is uniquely complementary to a sequence in the amplified region of C. trachomatis; (d) incubating the amplified target region(s), if any, with each of the oligonucleotide probes, under stringent conditions, and allowing for hybridization between each of said probes and the target region for said probe; and (e) detecting hybrids formed between the amplified target regions(s), if any, and the oligonucleotide probe(s).
Claim 2
Independent Claim
257 words
A method for determining the presence or absence of N. gonorrhoeae and/or C. trachomatis in a fluid sample suspected of containing either or both N. gonorrhoeae and C. trachomatis comprising: (a) treating said sample with an aqueous solution containing at least four oligonucleotide primers, two of said primers being capable of hybridizing selectively with the two complementary strands of N. gonorrhoeae DNA which contain the target sequence, said primers having SEQ ID NO: 1 and SEQ ID NO:2, respectively, and the other two primers being capable of hybridizing selectively with the two complementary strands of C. trachomatis DNA which contain the target sequence, said primers having SEQ ID NO:4 and SEQ ID NO:5, respectively, said aqueous solution also containing an inert organic polar solvent as a cosolvent; (b) synthesizing an extension product of each of said primers, which extension product(s) containing the target DNA sequence(s), and amplifying said target sequences(s) if present; (c) treating said sample, after the intended amplification(s), with two oligonucleotide probes: one probe having sequence SEQ ID NO:3 which is uniquely complementary to a sequence in the amplified region of N. gonorrhoeae, and a second probe having sequence SEQ ID NO:6 which is uniquely complementary to a sequence in the amplified region of C. trachomatis; (d) incubating the amplified target region(s), if any, with each of the oligonucleotide probes, under stringent conditions, and allowing for hybridization between each of said probes and the target region for said probe; and (e) detecting hybrids formed between the amplified target regions(s), if any, and the oligonucleotide probe(s).
Claim 3
Dependent Claim
17 words
The method of claim 1, wherein Step (d) is carried out in the presence of a buffer.
Claim 4
Dependent Claim
16 words
The method of claim 2 wherein the buffer comprises NaSCN at a concentration of about 4.0M.
Claim 5
Dependent Claim
81 words
A PCR kit for the detection of either or both N. gonorrhoeae and C. trachomatis, comprising a container having an aqueous solution which includes oligonucleotide primers having sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:5, said aqueous solution further containing as a cosolvent an organic polar solvent; and separate from said container, an oligonucleotide probe for N. gonorrhoeae having sequence SEQ ID NO:3 and a probe for C. trachomatis having the sequence SEQ ID NO:6.
Claim 6
Dependent Claim
81 words
A PCR kit for the detection of either or both N. gonorrhoeae and C. trachomatis, comprising a container having an aqueous solution which includes oligonucleotide primers having sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:5, said aqueous solution further containing as a cosolvent an organic polar solvent; and separate from said container, an oligonucleotide probe for N. gonorrhoeae having sequence SEQ ID NO:3 and a probe for C. trachomatis having the sequence SEQ ID NO:6.
Claim 7
Dependent Claim
14 words
The kit of claim 4 wherein the probes are immobilized on a microtiter plate.
Claim 8
Dependent Claim
11 words
The kit of claim 5 wherein the oligonucleotide primers are labeled.
Claim 9
Dependent Claim
12 words
The kit of claim 6 wherein the primers are labeled with biotin.
Claim 10
Dependent Claim
25 words
The kit of claim 4 wherein said cosolvent is present in an amount of from about 1% to about 20% by volume of said solution.
References Cited (Backward Citations)
US5132207A
Cited
US4755458A
Cited
US4767699A
Cited
EP0237737A2
Cited
US4900659A
Cited
US4683195B1
Cited
US4683195A
Cited
US5333675A
Cited
US5333675C1
Cited
WO1988003957A1
Cited
US5047523A
Cited
US5075216A
Cited
US5432271A
Cited
US5162199A
Cited
US5232829A
Cited
US5256536A
Cited
US5378606A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-08-27 | 2000-02-26 | 2000-08-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-08-27 | 2004-02-26 | 2004-08-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-08-27 | 2008-02-26 | 2008-08-27 | $7700.00 | Window Closed / Lapsed |